NRX Pharmaceuticals, Inc. (NRXP)
4.445
+0.16
(+3.86%)
USD |
NASDAQ |
May 28, 16:00
4.37
-0.08
(-1.69%)
After-Hours: 19:07
NRX Pharmaceuticals Shareholders Equity (Quarterly) : -13.82M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| IGC Pharma, Inc. | 6.121M |
| Definium Therapeutics, Inc. | 278.85M |
| Atai Beckley, Inc. | 198.68M |
| Alto Neuroscience, Inc. | 243.37M |
| LENZ Therapeutics, Inc. | 246.49M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.90M |
| Total Liabilities (Quarterly) | 25.72M |
| Debt to Equity Ratio | -0.0676 |
| Current Ratio | 0.2924 |
| Net Debt Paydown Yield | 1.58% |